Skip to content

AptarGroup ATR Pharma — Net Sales

Similar metrics at other companies

Baxter International logo
BAXPharmaceuticals — Net Sales
$621M+6.9%
Vertex Pharmaceuticals logo
VRTXPharmaceuticals — Product revenues, net
$2.99B+7.8%
Incyte logo
INCYNet sales — Total revenues
$1.1B+19.8%
Bristol-Myers Squibb logo
BMYNet product sales — Total Revenues
$11.17B+2.6%
Viatris logo
VTRSBrands — Net Sales
$2.33B+10.2%
Enpro logo
NPOFood and biopharmaceutical — Net Sales
$19.08M+12.7%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's pharma — net sales?
AptarGroup (ATR) reported pharma — net sales of $438.91M in Q1 2026.
How has AptarGroup's pharma — net sales changed year-over-year?
AptarGroup's pharma — net sales increased by 7.1% year-over-year, from $409.7M to $438.91M.
What does pharma — net sales mean?
Represents the total revenue generated from the sale of dispensing systems to pharmaceutical and healthcare clients, net of returns and allowances. This is the primary indicator of market demand for the segment's specialized packaging products.